FundLens
45
Pharma & HealthcareHold

Bajaj Finserv Healthcare

Bajaj Finserv · Direct–Growth · rank #10 of 19 by Smart Score

Data updated

Trailing returns

vs Nifty 500 (index-fund proxy)
1 Year
24.2%
+23.4% vs index
3 Years
—
5 Years
—
Since launch
12.1%

Year-by-year performance

last entry = YTD
2025
-2.9%
2026
+27.6%

Why this score

Bajaj Finserv Healthcare scores 45/100 — #10 of 19 Pharma & Healthcare fund (Hold). It stands out for expense ratio and volatility — beating 81% of peers on expense ratio. The main drag is its sharpe ratio (better than only 9% of peers).

Each bar shows the fund's percentile vs Pharma & Healthcare peers — a longer bar beats more of the category.

Sharpe ratio0.41 · 9th percentile in category
Sortino ratio0.57 · 10th percentile in category
Expense ratio0.90% · 81st percentile in category
Volatility13.72 · 72nd percentile in category
Fund size418.66 Cr · 29th percentile in category
Alpha6.14 · 66th percentile in category

Top holdings

top 5 = 36.7% of portfolio
1.Divi's Laboratories Ltd8.76%
2.Sun Pharmaceutical Industries Ltd8.48%
3.Piramal Pharma Ltd7.11%
4.Apollo Hospitals Enterprise Ltd6.44%
5.Aurobindo Pharma Ltd5.87%

33 disclosed equity positions · portfolio as of Oct 2026 · weights are % of total corpus.

Other Pharma & Healthcare funds